12 West Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,348
| Closed | -$2.06M | – | 16 |
|
|
2020
Q3 | $2.06M | Hold |
6,348
| – | – | 0.1% | 16 |
|
|
2020
Q2 | $2.31M | Hold |
6,348
| – | – | 0.12% | 15 |
|
|
2020
Q1 | $1.35M | Hold |
6,348
| – | – | 0.08% | 16 |
|
|
2019
Q4 | $2.61M | Hold |
6,348
| – | – | 0.16% | 12 |
|
|
2019
Q3 | $2.24M | Hold |
6,348
| – | – | 0.14% | 13 |
|
|
2019
Q2 | $3.19M | Hold |
6,348
| – | – | 0.24% | 13 |
|
|
2019
Q1 | $6.31M | Hold |
6,348
| – | – | 0.51% | 11 |
|
|
2018
Q4 | $5.51M | Hold |
6,348
| – | – | 0.57% | 14 |
|
|
2018
Q3 | $6.56M | Hold |
6,348
| – | – | 0.48% | 17 |
|
|
2018
Q2 | $5.83M | Sell |
6,348
-800
| -11% | -$735K | 0.48% | 18 |
|
|
2018
Q1 | $6.97M | Sell |
7,148
-8,800
| -55% | -$8.58M | 0.77% | 17 |
|
|
2017
Q4 | $7.22M | Hold |
15,948
| – | – | 0.87% | 17 |
|
|
2017
Q3 | $6.6M | Hold |
15,948
| – | – | 0.92% | 15 |
|
|
2017
Q2 | $5.58M | Hold |
15,948
| – | – | 0.94% | 13 |
|
|
2017
Q1 | $8.19M | Hold |
15,948
| – | – | 1.63% | 13 |
|
|
2016
Q4 | $5.66M | Hold |
15,948
| – | – | 1.01% | 13 |
|
|
2016
Q3 | $8.53M | Hold |
15,948
| – | – | 1.22% | 13 |
|
|
2016
Q2 | $8.98M | Hold |
15,948
| – | – | 1.45% | 13 |
|
|
2016
Q1 | $7.59M | Buy |
15,948
+200
| +1% | +$95.1K | 1.05% | 17 |
|
|
2015
Q4 | $10.4M | Buy |
15,748
+6,480
| +70% | +$4.28M | 1.48% | 13 |
|
|
2015
Q3 | $7.29M | Buy |
9,268
+3,050
| +49% | +$2.4M | 1.06% | 14 |
|
|
2015
Q2 | $8.2M | Buy |
+6,218
| New | +$8.2M | 0.94% | 16 |
|